CL2017002726A1 - Método cosmético y uso terapéutico para la reducción de grasa - Google Patents

Método cosmético y uso terapéutico para la reducción de grasa

Info

Publication number
CL2017002726A1
CL2017002726A1 CL2017002726A CL2017002726A CL2017002726A1 CL 2017002726 A1 CL2017002726 A1 CL 2017002726A1 CL 2017002726 A CL2017002726 A CL 2017002726A CL 2017002726 A CL2017002726 A CL 2017002726A CL 2017002726 A1 CL2017002726 A1 CL 2017002726A1
Authority
CL
Chile
Prior art keywords
fat reduction
therapeutic use
cosmetic method
fat
reduction
Prior art date
Application number
CL2017002726A
Other languages
English (en)
Inventor
Jenny W Wang
David F Woodward
Neil J Poloso
Robert M Burk
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of CL2017002726A1 publication Critical patent/CL2017002726A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/559—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing hetero atoms other than oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

<p>En este documento se describen métodos Compuestos y composiciones para la reducción de grasa, en particular para la reducción de grasa sn crecimiento significativo y/o adicional de pelo.</p>
CL2017002726A 2015-04-30 2017-10-26 Método cosmético y uso terapéutico para la reducción de grasa CL2017002726A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562154926P 2015-04-30 2015-04-30

Publications (1)

Publication Number Publication Date
CL2017002726A1 true CL2017002726A1 (es) 2018-05-04

Family

ID=56072424

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017002726A CL2017002726A1 (es) 2015-04-30 2017-10-26 Método cosmético y uso terapéutico para la reducción de grasa

Country Status (15)

Country Link
US (2) US9795615B2 (es)
EP (2) EP3288559B1 (es)
JP (1) JP6796601B2 (es)
KR (1) KR102159427B1 (es)
CN (1) CN107660145B (es)
AU (1) AU2016254208B2 (es)
BR (1) BR112017023316A2 (es)
CA (1) CA2983942A1 (es)
CL (1) CL2017002726A1 (es)
IL (2) IL255318B (es)
MX (1) MX385254B (es)
RU (1) RU2017140078A (es)
SG (1) SG11201708827SA (es)
UA (1) UA120775C2 (es)
WO (1) WO2016176640A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016520561A (ja) 2013-04-12 2016-07-14 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ 脂肪減少のためのビマトプロスト、ビマトプロスト類似体、プロスタミド及びプロスタグランジンの持続放出
WO2016176640A1 (en) 2015-04-30 2016-11-03 Allergan, Inc. Cosmetic method and therapeutic use for fat reduction
WO2020181232A1 (en) 2019-03-06 2020-09-10 C4 Therapeutics, Inc. Heterocyclic compounds for medical treatment
US11452703B2 (en) 2020-05-21 2022-09-27 Peregrine Ophthalmic PTE LTD. Methods and compositions for reducing adipocyte numbers

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6602900B2 (en) * 1992-09-21 2003-08-05 Allergan, Inc. Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US6124344A (en) 1993-12-28 2000-09-26 Allergan Sales, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
WO1996036599A1 (en) 1995-05-18 1996-11-21 Allergan Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension
US5741810A (en) * 1996-02-29 1998-04-21 Allergan Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents
US7666912B2 (en) 2006-03-23 2010-02-23 Massachusetts Eye And Ear Infirmary Compositions and methods for reducing body fat
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
FR2920309B1 (fr) * 2007-08-28 2010-05-28 Galderma Res & Dev Utilisation de travoprost pour traiter la chute des cheveux
US9149484B2 (en) 2009-11-09 2015-10-06 Allergan, Inc. Compositions and methods for stimulating hair growth
US20130071349A1 (en) 2010-03-02 2013-03-21 Allergan, Inc. Biodegradable polymers for lowering intraocular pressure
CA2867901A1 (en) * 2012-03-21 2013-09-26 The Trustees Of The University Of Pennsylvania Compositions and methods for regulating hair growth
HK1220385A1 (zh) 2013-03-15 2017-05-05 Allergan, Inc. 用於增加瘦素生成的比马前列素
JP2016520561A (ja) 2013-04-12 2016-07-14 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ 脂肪減少のためのビマトプロスト、ビマトプロスト類似体、プロスタミド及びプロスタグランジンの持続放出
NO2753788T3 (es) * 2013-05-10 2018-06-16
US10188661B2 (en) * 2014-06-27 2019-01-29 Topokine Therapeutics, Inc. Topical dosage regimen
WO2016176640A1 (en) 2015-04-30 2016-11-03 Allergan, Inc. Cosmetic method and therapeutic use for fat reduction

Also Published As

Publication number Publication date
KR102159427B1 (ko) 2020-09-24
UA120775C2 (uk) 2020-02-10
BR112017023316A2 (pt) 2018-08-14
EP3288559A1 (en) 2018-03-07
MX385254B (es) 2025-03-14
JP2018514554A (ja) 2018-06-07
SG11201708827SA (en) 2017-11-29
IL255318A0 (en) 2017-12-31
RU2017140078A3 (es) 2019-08-06
AU2016254208B2 (en) 2021-07-15
WO2016176640A1 (en) 2016-11-03
CN107660145B (zh) 2021-04-20
EP3288559B1 (en) 2020-06-24
HK1250483A1 (zh) 2018-12-21
CN107660145A (zh) 2018-02-02
KR20170141770A (ko) 2017-12-26
IL255318B (en) 2021-05-31
CA2983942A1 (en) 2016-11-03
RU2017140078A (ru) 2019-05-30
AU2016254208A1 (en) 2017-11-16
US9795615B2 (en) 2017-10-24
IL282473A (en) 2021-06-30
MX2017013819A (es) 2018-02-21
JP6796601B2 (ja) 2020-12-09
EP3721885A1 (en) 2020-10-14
US20180071308A1 (en) 2018-03-15
US20160317550A1 (en) 2016-11-03
US10117877B2 (en) 2018-11-06

Similar Documents

Publication Publication Date Title
BR112017024899A2 (pt) proteínas de ligação trispecíficas e métodos de uso.
MX375032B (es) Proteínas de unión y métodos para utilizarlas.
GB201700510D0 (en) Composition, kit and method for colouring keratinous fibers
PT3378859T (pt) Derivado de benzofurano, método de preparação do mesmo e uso do mesmo em medicina
EP3395012A4 (en) Fingerprinting root cause analysis in cellular systems
CR20180013A (es) Anticuerpos anti-tau y métodos de uso.
EP3268050A4 (en) Pore-forming protein conjugate compositions and methods
NZ720769A (en) Anti-siglec-8 antibodies and methods of use thereof
GB201904104D0 (en) Composition, method and use
GB201617572D0 (en) Use, method, kit, composition and antibodies
ZA201707494B (en) Hair regrowth treatment and growth stimulant
IL256833A (en) Il-17f-specific capture agents, compositions, and methods of using and making
BR112016027043A2 (pt) Combinação, composição farmacêutica compreendendo glucocorticoide e edo-s101, kit e uso no tratamento de câncer
IL285792A (en) Composition and container, kit, method of use
EP3442497B8 (en) Active combinations, compositions and methods for enhancing hair growth
CL2017002726A1 (es) Método cosmético y uso terapéutico para la reducción de grasa
EP3376226A4 (en) Method and kit for preparing antibody pair and use of kit, and system for preparing antibody pair
EP3197443A4 (en) Compositions and methods for enhancing hair growth, promoting skin regeneration, and wound healing
BR112018006560A2 (pt) composições para higiene bucal e métodos de uso das composições.
MX2022012748A (es) Composicion biocida y metodo.
MX372759B (es) Composiciones para usarse en mejorar la función renal.
GB201705088D0 (en) Composition, method and use
SG10201603101YA (en) Lubricant composition, and preparation method and use thereof
BR112018006204A2 (pt) composições para higiene bucal e métodos de uso das composições.
ZA202004991B (en) New spirooxathiolanone compounds, their preparation method as well as their use in perfume-making and aromatics industry